These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

728 related articles for article (PubMed ID: 22850358)

  • 1. Effect of intermittent preventive treatment for malaria during infancy on serological responses to measles and other vaccines used in the Expanded Programme on Immunization: results from five randomised controlled trials.
    Crawley J; Sismanidis C; Goodman T; Milligan P;
    Lancet; 2012 Sep; 380(9846):1001-10. PubMed ID: 22850358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective efficacy and safety of three antimalarial regimens for intermittent preventive treatment for malaria in infants: a randomised, double-blind, placebo-controlled trial.
    Gosling RD; Gesase S; Mosha JF; Carneiro I; Hashim R; Lemnge M; Mosha FW; Greenwood B; Chandramohan D
    Lancet; 2009 Oct; 374(9700):1521-32. PubMed ID: 19765815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in African infants: a pooled analysis of six randomised, placebo-controlled trials.
    Aponte JJ; Schellenberg D; Egan A; Breckenridge A; Carneiro I; Critchley J; Danquah I; Dodoo A; Kobbe R; Lell B; May J; Premji Z; Sanz S; Sevene E; Soulaymani-Becheikh R; Winstanley P; Adjei S; Anemana S; Chandramohan D; Issifou S; Mockenhaupt F; Owusu-Agyei S; Greenwood B; Grobusch MP; Kremsner PG; Macete E; Mshinda H; Newman RD; Slutsker L; Tanner M; Alonso P; Menendez C
    Lancet; 2009 Oct; 374(9700):1533-42. PubMed ID: 19765816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increase in EPI vaccines coverage after implementation of intermittent preventive treatment of malaria in infant with Sulfadoxine -pyrimethamine in the district of Kolokani, Mali: results from a cluster randomized control trial.
    Dicko A; Toure SO; Traore M; Sagara I; Toure OB; Sissoko MS; Diallo AT; Rogier C; Salomon R; de Sousa A; Doumbo OK
    BMC Public Health; 2011 Jul; 11():573. PubMed ID: 21767403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intermittent treatment for malaria and anaemia control at time of routine vaccinations in Tanzanian infants: a randomised, placebo-controlled trial.
    Schellenberg D; Menendez C; Kahigwa E; Aponte J; Vidal J; Tanner M; Mshinda H; Alonso P
    Lancet; 2001 May; 357(9267):1471-7. PubMed ID: 11377597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acceptability of coupling intermittent preventive treatment in infants with the expanded programme on immunization in three francophone countries in Africa.
    de Sousa A; Rabarijaona LP; Ndiaye JL; Sow D; Ndyiae M; Hassan J; Lambo N; Adovohekpe P; Guidetti F; Recht J; Affo A
    Trop Med Int Health; 2012 Mar; 17(3):308-15. PubMed ID: 22128893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized controlled trial of extended intermittent preventive antimalarial treatment in infants.
    Kobbe R; Kreuzberg C; Adjei S; Thompson B; Langefeld I; Thompson PA; Abruquah HH; Kreuels B; Ayim M; Busch W; Marks F; Amoah K; Opoku E; Meyer CG; Adjei O; May J
    Clin Infect Dis; 2007 Jul; 45(1):16-25. PubMed ID: 17554695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malaria chemoprophylaxis and the serologic response to measles and diphtheria-tetanus-whole-cell pertussis vaccines.
    Rosen JB; Breman JG; Manclark CR; Meade BD; Collins WE; Lobel HO; Saliou P; Roberts JM; Campaoré P; Miller MA
    Malar J; 2005 Nov; 4():53. PubMed ID: 16271153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intermittent preventive treatment for malaria control administered at the time of routine vaccinations in Mozambican infants: a randomized, placebo-controlled trial.
    Macete E; Aide P; Aponte JJ; Sanz S; Mandomando I; Espasa M; Sigauque B; Dobaño C; Mabunda S; DgeDge M; Alonso P; Menendez C
    J Infect Dis; 2006 Aug; 194(3):276-85. PubMed ID: 16826474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intermittent preventive treatment for malaria in infants.
    Esu EB; Oringanje C; Meremikwu MM
    Cochrane Database Syst Rev; 2021 Jul; 7(7):CD011525. PubMed ID: 34273901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intermittent preventive treatment in infants as a means of malaria control: a randomized, double-blind, placebo-controlled trial in northern Ghana.
    Mockenhaupt FP; Reither K; Zanger P; Roepcke F; Danquah I; Saad E; Ziniel P; Dzisi SY; Frempong M; Agana-Nsiire P; Amoo-Sakyi F; Otchwemah R; Cramer JP; Anemana SD; Dietz E; Bienzle U
    Antimicrob Agents Chemother; 2007 Sep; 51(9):3273-81. PubMed ID: 17638703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Varying efficacy of intermittent preventive treatment for malaria in infants in two similar trials: public health implications.
    Menendez C; Schellenberg D; Macete E; Aide P; Kahigwa E; Sanz S; Aponte JJ; Sacarlal J; Mshinda H; Tanner M; Alonso PL
    Malar J; 2007 Sep; 6():132. PubMed ID: 17897454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular markers of resistance to sulfadoxine-pyrimethamine during intermittent preventive treatment for malaria in Mozambican infants.
    Mayor A; Serra-Casas E; Sanz S; Aponte JJ; Macete E; Mandomando I; Puyol L; Berzosa P; Dobaño C; Aide P; Sacarlal J; Benito A; Alonso P; Menéndez C
    J Infect Dis; 2008 Jun; 197(12):1737-42. PubMed ID: 18419347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of oral azithromycin and intermittent preventive treatment with sulfadoxine-pyrimethamine regimen on child mortality in Sierra Leone: trial protocol for a randomised, two-arm, double-blinded, placebo-controlled clinical trial (ICARIA).
    Owusu-Kyei K; Chen H; Chileshe M; Quintó L; Sibley M; Figueroa-Romero A; Llach M; Ramírez M; Bofill A; Samai M; Menéndez C;
    Trials; 2024 Sep; 25(1):626. PubMed ID: 39334260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cluster randomised trial of intermittent preventive treatment for malaria in infants in area of high, seasonal transmission in Ghana.
    Chandramohan D; Owusu-Agyei S; Carneiro I; Awine T; Amponsa-Achiano K; Mensah N; Jaffar S; Baiden R; Hodgson A; Binka F; Greenwood B
    BMJ; 2005 Oct; 331(7519):727-33. PubMed ID: 16195288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modelling the protective efficacy of alternative delivery schedules for intermittent preventive treatment of malaria in infants and children.
    Cairns M; Ghani A; Okell L; Gosling R; Carneiro I; Anto F; Asoala V; Owusu-Agyei S; Greenwood B; Chandramohan D; Milligan P
    PLoS One; 2011 Apr; 6(4):e18947. PubMed ID: 21533088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risks of Hemolysis in Glucose-6-Phosphate Dehydrogenase Deficient Infants Exposed to Chlorproguanil-Dapsone, Mefloquine and Sulfadoxine-Pyrimethamine as Part of Intermittent Presumptive Treatment of Malaria in Infants.
    Poirot E; Vittinghoff E; Ishengoma D; Alifrangis M; Carneiro I; Hashim R; Baraka V; Mosha J; Gesase S; Chandramohan D; Gosling R
    PLoS One; 2015; 10(11):e0142414. PubMed ID: 26599634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intermittent preventive treatment for malaria in infants.
    Esu EB; Oringanje C; Meremikwu MM
    Cochrane Database Syst Rev; 2019 Dec; 12(12):CD011525. PubMed ID: 31792925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EPI vaccines-induced antibody prevalence in 8-9 year-olds in The Gambia.
    Viviani S; Mendy M; Jack AD; Hall AJ; Montesano R; Whittle HC
    Trop Med Int Health; 2004 Oct; 9(10):1044-9. PubMed ID: 15482396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Duration of protection against clinical malaria provided by three regimens of intermittent preventive treatment in Tanzanian infants.
    Cairns M; Gosling R; Carneiro I; Gesase S; Mosha JF; Hashim R; Kaur H; Lemnge M; Mosha FW; Greenwood B; Chandramohan D
    PLoS One; 2010 Mar; 5(3):e9467. PubMed ID: 20209126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.